Prescribing information

 

_

Melanoma is a form cancer that originates from melanocytes, the pigment-producing cells predominantly found in the skin.1

Melanoma accounts for only 4% of all skin cancers; however, melanoma is responsible for 80% of deaths from skin cancer.2

Melanoma is the fifth most common cancer in the UK, accounting for 5% of all new cancer cases in 2016.3

Melanoma is most commonly diagnosed in patients aged 85–89 years.3

References

  1. American Cancer Society. What is melanoma skin cancer? Available at: https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanom... (accessed January 2020).
  2. Miller AJ and Mihm MC. N Engl J Med 2006;335:51–65.
  3. Cancer Research UK. Melanoma skin cancer statistics. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s... (accessed January 2020).
TMC20-C004k May 2020
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the patient safety information (PSI) tool at https://psi.novartis.com
If you have a question about the product, please contact Medical Information on 01276 692255 or by email at [email protected]